Denial summary and financial impact
Denied amounts, counts and rates summarized to show the size of the problem and where revenue is affected.
Product
DenialIntel turns healthcare transaction and denial data into evidence that revenue-cycle teams and management can act on. This page describes what the application does — capabilities you can explore in the synthetic demo.
DenialIntel is designed for organizations working denials on the provider side of the revenue cycle, and for the teams and leaders responsible for that work.
It provides operational and financial decision support. It does not provide clinical decision support.
See the scale of denials, where they are concentrated and how they are changing.
Denied amounts, counts and rates summarized to show the size of the problem and where revenue is affected.
Compare denial volume, value and rates across payers.
See which departments are associated with denial volume and value.
Track denial rates and trends over time to see whether patterns are improving or worsening.
Look beyond the adjustment code to what the connected transaction record shows.
Review a denied claim alongside its matched remittance, adjustment amounts and reason codes.
Review 270/271 eligibility information relevant to a denial, where available.
Review 278 authorization information relevant to a denial, where available.
View denial history and related activity at patient or case level. The public demo uses synthetic records only.
Move from reporting denials to working them.
See how long denials have been outstanding so time-sensitive work is visible.
A prioritized list of denials needing attention, supported by value, ageing and transaction evidence.
Export analysis and worklists to Excel and reports for team workflows and management reporting.
Find patterns and likely contributing causes worth investigating.
Identifies likely contributing causes for investigation and human review. It is a starting point for review, not a final determination.
Highlights patterns, concentrations and changes in denial activity.
Machine-learning analysis highlights patterns and risk indicators that support review and prioritization. Its outputs are supporting signals, not authoritative decisions.
AI explains findings that the deterministic analysis has already established.
Concise summaries of established findings, written for quick review.
A longer narrative explanation of a denial pattern or area, grounded in the established evidence.
AI is optional. It does not perform core calculations, make clinical decisions, decide whether a claim must be paid or replace professional and payer-policy review. In the public demo, AI output is representative and pre-generated.
Where is revenue being lost? What deserves management attention?
What happened? Is action possible? What evidence supports it?
What process or upstream issue is repeatedly producing the denial?
The public demonstration requires no login and contains synthetic data only.
Synthetic demonstration data only. Do not enter PHI or other sensitive personal information.